Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam or no premedication for postoperative inflammation in children undergoing day-surgery hernia repair
ChiCTR1900026795Phase 4Recruiting
- Sponsor
- Hunan Children's Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and midazolam in indirect inguinal hernia (IIH) (3 arms), sponsored by Hunan Children's Hospital. Primary endpoints: Tumor necrosis factor alpha, Interleukin 6 and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
indirect inguinal hernia (IIH)
Beyond the preview
Go deeper on ChiCTR1900026795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026795.